Suchergebnisse - "Ku, Bo Mi"

PubPharm (90)

1

Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer

enthalten in: bioRxiv.org | 2024

von Kim, N. | Park, S. | Jo, A. | +18

2

Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Jung, H. | Ku, B. | Kim, Y. | +15

CommentIn: J Thorac Oncol. 2023 Sep;18(9):1118-1120. - PMID 37599043

3

Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer

enthalten in: International journal of radiation oncology, biology, physics | 2023

von Kim, K. | Pyo, H. | Lee, H. | +15

4

A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Jung, H. | Kim, M. | Kim, H. | +12

5

Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors

enthalten in: Cancer medicine | 2022

von Kwon, M. | Ku, B. | Olsen, S. | +9

6

Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy

enthalten in: International journal of radiation oncology, biology, physics | 2022

von Kim, K. | Pyo, H. | Lee, H. | +15

7

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancer

enthalten in: Investigational new drugs | 2022

von Ku, B. | Heo, J. | Kim, J. | +5

8

Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor

enthalten in: Oncology | 2022

von Ku, B. | Kim, Y. | Park, D. | +5

9

Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma

enthalten in: PloS one | 2022

von Hur, J. | Ku, B. | Park, S. | +3

10

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

enthalten in: Investigational new drugs | 2022

von Ku, B. | Heo, J. | Kim, J. | +5

1
2
3
4
5
6
7
8
9
Nächster »
[9]